The skin replacement market share is expected to increase at a 6.4 percent CAGR from USD 838.0 million in 2018 to USD 1,202.2 million in 2024. The rising frequency of dermatological disorders is a major driving force for the demand for skin replacement.
Report Attributes | Details |
---|---|
Estimated Base Year Value (2018) | USD 838 Million |
Expected Market Value (2024) | USD 1202.2 Million |
Projected Growth Rate (2022 to 2032) | 6.4% CAGR |
The primary growth drivers for the skin replacement market during the study period are predicted to be an increase in global life expectancy, advancements in skin replacement technologies, and increased healthcare spending.
The rising number of burn patients is another important factor driving the skin replacement market share forward. According to research published by the World Health Organization, the bulk of the 180,000 global deaths related to burn injuries each year occur in low and middle-income nations.
In nations like Egypt, Bangladesh, Pakistan, and Colombia, many children with burns become crippled as a result of the severity of the condition and inadequate medical care. Skin replacement and substitute goods are extremely beneficial in the treatment of burn wounds.
Geographically, North America dominated the skin replacement market, owing to world-class healthcare infrastructure, sophisticated facilities, increased awareness, increased technological penetration, and increased citizen spending on healthcare. Europe and Asia-Pacific had the second and third largest demand for skin replacement, respectively.
Asia Pacific is expected to have the fastest growth in rising demand for skin replacement owing to the broadening healthcare systems, rising expenditure, public programs, and increasing human awareness, as well as a growing medical tourism business in developing countries like China and India.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Skin is the largest organ in the human body which is highly dynamic in nature. It is composed of two layers; the outer layer called the epidermis and the inner layer called the dermis. Its network of nerves, blood vessels and cells thus act as protective armor. It serves the body in diverse ways. It's of paramount importance owing to its protective functionality.
The skin’s protective function creates a barrier for internal organs and tissues from toxins, disease-carrying microbes, heat and cold, and other dangers present in the environment. It also plays a significant role in regulating the body temperature and preserving the body's fluid balance. Nerves within the skin sense the presence of potentially harmful agents, such as bees, and immune cells in the skin help to fight against these malicious agents.
For the aforementioned reasons, the loss of skin due to burns or trauma can cause a severe blow to the human body; leading to impairment or sometimes elimination of many vital functions that it typically performs.
The artificial skin can be easily sterilized and usually stored at room temperature. Skin replacement represents a prospective source of advanced therapy in combating acute and chronic skin wounds. With the capability of large-scale production and immediate availability for grafting, its potential for use is easy and relatively economic among the burn patients.
Much progress has been made toward the development of artificial skin replacement products. Continued research promises a growth in the demand for skin replacement products to the marketplace, and each new product seems to develop a niche in the field of skin replacement. Increased life expectancy, increasing disposable income and favorable demographics are some of the key factors driving the growth of the global skin replacement market.
Bioengineered skin replacements are continually being developed and improved. The next generation of skin replacements will probably evolve from lessons learned from our understanding of wound repair and regeneration. Competition from low-cost substitutes, lack of clinical support are probable factors restraining the growth of the global skin replacement market.
Though skin replacement is a new technology for emerging economies, in developed nations the same technology has been in use for a few decades. With increasing disposable income and rising urbanization, the acceptance of skin replacements is gaining popularity. The global skin replacement market is expected to expand at a promising CAGR during the forecast period.
Skin replacement market is still in its early stage of maturity. The global skin replacement market is expected to register an optimistic CAGR for the forecast period. Depending on geographic regions, global skin replacement market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
Report Attributes | Details |
---|---|
Growth rate | CAGR of 6.4% from 2022 to 2032 |
Base year for estimation | 2021 |
Historical data | 2015 to 2020 |
Forecast period | 2022 to 2032 |
Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
Segments covered | Product, application, end user, region |
Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia |
Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
Key companies profiled | Platelet BioGenesis; Cynata Therapeutics Limited; TissueGene, Inc.; Cellular Dynamics International; Tengion |
Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key market participants in the global skin replacement market are Platelet BioGenesis, Cynata Therapeutics Limited, TissueGene, Inc., Cellular Dynamics International, and Tengion.
North America had the biggest demand for skin replacement products during the period.
Asia Pacific is expected to have the quickest growth in skin replacement market share.
The skin replacement market share is anticipated to grow at a CAGR of 6.4% during the forecast period.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Allograft 5.2. Autograft 5.3. Xenograft 5.4. Synthetic 5.5. Alloplast 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Usability 6.1. Temporary Skin Replacement 6.2. Permanent Skin Replacement 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Material Type 7.1. Natural Material 7.2. Synthetic Material 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 8.1. Hospitals 8.2. Ambulatory Surgical Centers 8.3. Clinics 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 9.1. North America 9.2. Latin America 9.3. Europe 9.4. East Asia 9.5. South Asia & Pacific 9.6. MEA 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14. South Asia & Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. B. Braun Melsungen AG 18.2. Baxter 18.3. Becton, Dickinson and Company 18.4. Johnson & Johnson Private Limited 18.5. Stryker 18.6. Integra LifeSciences Corporation 18.7. Medtronic 18.8. Acera Surgical, Inc. 18.9. Arthrex, Inc. 18.10. Acelity L.P. Inc. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports